[Risky to combine clopidogrel with proton pump inhibitor?].
ulrika.wall@vgregion.se
Ulrika
U
Wall
Lennart
L
Andrén
D000897:Anti-Ulcer Agents / Q000009:adverse effects; D001189:Aryl Hydrocarbon Hydroxylases / Q000037:antagonists & inhibitors; D000077144:Clopidogrel; D065731:Cytochrome P-450 CYP2C19; D004346:Drug Information Services; D004347:Drug Interactions; D004791:Enzyme Inhibitors / Q000009:adverse effects; D006801:Humans; D009853:Omeprazole / Q000009:adverse effects*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D054328:Proton Pump Inhibitors / Q000009:adverse effects*; D012307:Risk Factors; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives*
D000897:Anti-Ulcer Agents; D004791:Enzyme Inhibitors; D010975:Platelet Aggregation Inhibitors; D054328:Proton Pump Inhibitors; D000077144:Clopidogrel; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D009853:Omeprazole; D013988:Ticlopidine